AOA DX Inc. — Form D
AOA DX Inc. of Denver, CO, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-15. The offering totals $30.6M, of which $8.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-15
- Form: D
- Accession: 0001869920-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.6M
- Amount sold: $8.1M
- Remaining: $22.5M
- Investors: 40
- Date of first sale: 2025-10-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-560927
Issuer
- Name: AOA DX Inc.
- CIK: 0001869920
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6860 Broadway, Denver, CO, 80221
- Phone: 617-903-0350
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| John Friedman | Director | New York, NY |
| Oriana Papin-Zoghbi | Director | Denver, CO |
| Surbhi Sarna | Director | Denver, CO |
| Alexander James Fisher | Executive Officer | Denver, CO |
| Anna Milik Jeter | Executive Officer | Denver, CO |
| Abigail James Mcelhinny | Executive Officer | Denver, CO |
| Oriana Papin-Zoghbi | Executive Officer | Denver, CO |
| Alexander James Fisher | Director | Denver, CO |
| Alexander Fisher | Director | Bloomfield Hills, MI |
| Alexander Fisher | Executive Officer | Bloomfield Hills, MI |
| Anna Milik Jeter | Director | Jersey City, NJ |
| Anna Milik Jeter | Executive Officer | Jersey City, NJ |
| Oriana Zoghbi-Harb | Director | Jersey City, NJ |
| Oriana Zoghbi-Harb | Executive Officer | Jersey City, NJ |
Other filings by this issuer (4)
More